News and Highlights

Monday, 07 February 2022

Promising Drug Candidate Licensed to Cancer Therapeutics Company

AuraTEX, a gold-based cancer drug developed by University of Texas at Austin researchers, has been licensed exclusively to OncoTex Inc., a cancer therapeutics company. In 2020, UT Austin chemists Jonathan Sessler and Jonathan Araumbula (now CEO of OncoTex), published a paper in the Journal of the American Chemical Society showing that AuraTex preve...